Skip to content
1887

Abstract

Proteins facilitating bacterial cell wall (CW) biosynthesis are crucial for survival and broadly remain the target of numerous antimicrobial agents. Herein, we focused on characterizing the physiological roles of low-molecular-weight penicillin-binding proteins (LMW PBPs), with -carboxypeptidase (-CPase) activity, in . Following various combinatorial gene deletions, cell viability, colony structure and the ability to produce biofilms remained unperturbed. Whilst small changes in cellular morphology and permeability were evident, hierarchical roles could not be ascribed to specific -CPase homologues. Strains exposed to lysozyme exhibited low levels of compensatory expression for the remaining homologues, but this was not evident for exposure to the CW-targeting Augmentin. When tested against a broader concentration range of various antibiotics, using MIC and spotting assays, only marginal changes in drug susceptibility were evident. Strains cultured under conditions of excess NaCl or enhanced pH levels grew normally. Given the established role of remodelling in -CPase enzymes of other bacteria, we further assessed whether the ability to repair lysozyme-induced CW damage was compromised. With the incorporation of the fluorescent -amino acid peptidoglycan probe, TAMRA--alanine, as a proxy for remodelling, no changes in staining patterns were evident. However, the frequency of cells containing unresolved septa increased in all mutant strains, suggesting a potential role for -CPases in the mycobacterial cell process. In conclusion, we have demonstrated that the combinatorial deletion of non-essential mycobacterial -CPase homologues largely has no significant impact on mycobacterial physiology or involvement in the response to the various environmental stressors tested herein.

Funding
This study was supported by the:
  • South African Medical Research Council
    • Principal Award Recipient: BaveshD. Kana
  • Department of Science and Innovation, South Africa
    • Principal Award Recipient: BaveshD. Kana
  • South African National Research Foundation
    • Principal Award Recipient: BaveshD. Kana
  • This is an open-access article distributed under the terms of the Creative Commons Attribution License.
Loading

Article metrics loading...

/content/journal/acmi/10.1099/acmi.0.001074.v4
2025-12-19
2026-02-17

Metrics

Loading full text...

Full text loading...

/deliver/fulltext/acmi/7/12/acmi001074.v4.html?itemId=/content/journal/acmi/10.1099/acmi.0.001074.v4&mimeType=html&fmt=ahah

References

  1. Bhat ZS, Rather MA, Maqbool M, Lah HU, Yousuf SK et al. Cell wall: a versatile fountain of drug targets in Mycobacterium tuberculosis. Biomed Pharmacother 2017; 95:1520–1534 [View Article] [PubMed]
    [Google Scholar]
  2. WHO WHO Announces Updated Definitions of Extensively Drug-Resistant Tuberculosis. Geneva, Switzerland: WHO; 2021
  3. Rozwarski DA, Grant GA, Barton DHR, Jacobs WR, Sacchettini JC. Modification of the NADH of the isoniazid target (InhA) from Mycobacterium tuberculosis. Science 1998; 279:98–102 [View Article] [PubMed]
    [Google Scholar]
  4. Pawar A, Jha P, Konwar C, Chaudhry U, Chopra M et al. Ethambutol targets the glutamate racemase of Mycobacterium tuberculosis—an enzyme involved in peptidoglycan biosynthesis. Appl Microbiol Biotechnol 2019; 103:843–851 [View Article]
    [Google Scholar]
  5. Kong K-F, Schneper L, Mathee K. Beta‐lactam antibiotics: from antibiosis to resistance and bacteriology. APMIS 2010; 118:1–36 [View Article]
    [Google Scholar]
  6. Panda AP, Pandey SD, Jain D, Ghosh AS. The MSMEG_1586 of M. smegmatis is a penicillin-interactive enzyme that can potentially hydrolyse aztreonam and cephalosporins. Curr Microbiol 2023; 81:26 [View Article] [PubMed]
    [Google Scholar]
  7. Tarashi S, Siadat SD, Fateh A. Nontuberculous mycobacterial resistance to antibiotics and disinfectants: challenges still ahead. Biomed Res Int 2022; 2022:8168750 [View Article] [PubMed]
    [Google Scholar]
  8. Ghuysen JM. Serine beta-lactamases and penicillin-binding proteins. Annu Rev Microbiol 1991; 45:37–67 [View Article] [PubMed]
    [Google Scholar]
  9. Sauvage E, Kerff F, Terrak M, Ayala JA, Charlier P. The penicillin-binding proteins: structure and role in peptidoglycan biosynthesis. FEMS Microbiol Rev 2008; 32:234–258 [View Article] [PubMed]
    [Google Scholar]
  10. Macheboeuf P, Contreras-Martel C, Job V, Dideberg O, Dessen A. Penicillin binding proteins: key players in bacterial cell cycle and drug resistance processes. FEMS Microbiol Rev 2006; 30:673–691 [View Article] [PubMed]
    [Google Scholar]
  11. Goffin C, Ghuysen JM. Multimodular penicillin-binding proteins: an enigmatic family of orthologs and paralogs. Microbiol Mol Biol Rev 1998; 62:1079–1093 [View Article]
    [Google Scholar]
  12. Ghosh AS, Chowdhury C, Nelson DE. Physiological functions of d-alanine carboxypeptidases in Escherichia coli. Trends Microbiol 2008; 16:309–317 [View Article]
    [Google Scholar]
  13. Kieser KJ, Boutte CC, Kester JC, Baer CE, Barczak AK et al. Phosphorylation of the peptidoglycan synthase pona1 governs the rate of polar elongation in mycobacteria. PLoS Pathog 2015; 11:e1005010 [View Article]
    [Google Scholar]
  14. Patru MM, Pavelka MS Jr. A role for the class a penicillin-binding protein pona2 in the survival of Mycobacterium smegmatis under conditions of nonreplication. J Bacteriol 2010; 192:3043–3054 [View Article]
    [Google Scholar]
  15. Meberg BM, Paulson AL, Priyadarshini R, Young KD. Endopeptidase penicillin-binding proteins 4 and 7 play auxiliary roles in determining uniform morphology of Escherichia coli. J Bacteriol 2004; 186:8326–8336 [View Article]
    [Google Scholar]
  16. Popham DL, Young KD. Role of penicillin-binding proteins in bacterial cell morphogenesis. Curr Opin Microbiol 2003; 6:594–599 [View Article]
    [Google Scholar]
  17. Potluri L-P, de Pedro MA, Young KD. Escherichia coli low-molecular-weight penicillin-binding proteins help orient septal ftsz, and their absence leads to asymmetric cell division and branching. Mol Microbiol 2012; 84:203–224 [View Article]
    [Google Scholar]
  18. Ghosh AS, Young KD. Sequences near the active site in chimeric penicillin binding proteins 5 and 6 affect uniform morphology of Escherichia coli. J Bacteriol 2003; 185:2178–2186 [View Article]
    [Google Scholar]
  19. Nelson DE, Ghosh AS, Paulson AL, Young KD. Contribution of membrane-binding and enzymatic domains of penicillin binding protein 5 to maintenance of uniform cellular morphology of Escherichia coli. J Bacteriol 2002; 184:3630–3639 [View Article]
    [Google Scholar]
  20. Machowski EE, Senzani S, Ealand C, Kana BD. Comparative genomics for mycobacterial peptidoglycan remodelling enzymes reveals extensive genetic multiplicity. BMC Microbiol 2014; 14:75 [View Article]
    [Google Scholar]
  21. Choi U, Park SH, Lee HB, Son JE, Lee CR. Coordinated and distinct roles of peptidoglycan carboxypeptidases DacC and DacA in cell growth and shape maintenance under stress conditions. Microbiol Spectr 2023; 11:e0001423 [View Article] [PubMed]
    [Google Scholar]
  22. Park SH, Choi U, Ryu S-H, Lee HB, Lee J-W et al. Divergent effects of peptidoglycan carboxypeptidase DacA on intrinsic β-lactam and vancomycin resistance. Microbiol Spectr 2022; 10:e0173422 [View Article] [PubMed]
    [Google Scholar]
  23. Popham DL, Gilmore ME, Setlow P. Roles of low-molecular-weight penicillin-binding proteins in Bacillus subtilis spore peptidoglycan synthesis and spore properties. J Bacteriol 1999; 181:126–132 [View Article] [PubMed]
    [Google Scholar]
  24. Pedersen LB, Murray T, Popham DL, Setlow P. Characterization of dacC, which encodes a new low-molecular-weight penicillin-binding protein in Bacillus subtilis. J Bacteriol 1998; 180:4967–4973 [View Article] [PubMed]
    [Google Scholar]
  25. Buchanan CE, Ling ML. Isolation and sequence analysis of dacB, which encodes a sporulation-specific penicillin-binding protein in Bacillus subtilis. J Bacteriol 1992; 174:1717–1725 [View Article] [PubMed]
    [Google Scholar]
  26. Ealand CS, Asmal R, Mashigo L, Campbell L, Kana BD. Characterization of putative DD-carboxypeptidase-encoding genes in Mycobacterium smegmatis. Sci Rep 2019; 9:5194 [View Article] [PubMed]
    [Google Scholar]
  27. Bansal A, Kar D, Murugan RA, Mallick S, Dutta M et al. A putative low-molecular-mass penicillin-binding protein (PBP) of Mycobacterium smegmatis exhibits prominent physiological characteristics of DD-carboxypeptidase and beta-lactamase. Microbiology 2015; 161:1081–1091 [View Article] [PubMed]
    [Google Scholar]
  28. Baranowski C, Welsh MA, Sham L-T, Eskandarian HA, Lim HC et al. Maturing Mycobacterium smegmatis peptidoglycan requires non-canonical crosslinks to maintain shape. Elife 2018; 7:e37516 [View Article] [PubMed]
    [Google Scholar]
  29. Mishra S, Shukla P, Bhaskar A, Anand K, Baloni P et al. Efficacy of β-lactam/β-lactamase inhibitor combination is linked to WhiB4-mediated changes in redox physiology of Mycobacterium tuberculosis. Elife 2017; 6:e25624 [View Article] [PubMed]
    [Google Scholar]
  30. Gordhan BG, Parish T. Gene Replacement using Pretreated DNA. Methods Mol Med 2001; 54:77–92 [View Article] [PubMed]
    [Google Scholar]
  31. Goude R, Parish T. Electroporation of mycobacteria. Methods Mol Biol 2009; 465:203–215 [View Article] [PubMed]
    [Google Scholar]
  32. Hsu Y-P, Rittichier J, Kuru E, Yablonowski J, Pasciak E et al. Full color palette of fluorescent d-amino acids for in situ labeling of bacterial cell walls. Chem Sci 2017; 8:6313–6321 [View Article] [PubMed]
    [Google Scholar]
  33. Senzani S, Li D, Bhaskar A, Ealand C, Chang J et al. An Amidase_3 domain-containing N-acetylmuramyl-L-alanine amidase is required for mycobacterial cell division. Sci Rep 2017; 7:1140 [View Article] [PubMed]
    [Google Scholar]
  34. Shaku MT, Ocius KL, Apostolos AJ, Pires MM, VanNieuwenhze MS et al. Amidation of glutamate residues in mycobacterial peptidoglycan is essential for cell wall cross-linking. Front Cell Infect Microbiol 2023; 13:1205829 [View Article] [PubMed]
    [Google Scholar]
  35. Miller C, Thomsen LE, Gaggero C, Mosseri R, Ingmer H et al. SOS response induction by beta-lactams and bacterial defense against antibiotic lethality. Science 2004; 305:1629–1631 [View Article] [PubMed]
    [Google Scholar]
  36. Aldridge BB, Fernandez-Suarez M, Heller D, Ambravaneswaran V, Irimia D et al. Asymmetry and aging of mycobacterial cells lead to variable growth and antibiotic susceptibility. Science 2012; 335:100–104 [View Article] [PubMed]
    [Google Scholar]
  37. Zhydzetski A, Głowacka-Grzyb Z, Bukowski M, Żądło T, Bonar E et al. Agents targeting the bacterial cell wall as tools to combat gram-positive pathogens. Molecules 2024; 29:4065 [View Article] [PubMed]
    [Google Scholar]
  38. Shan L, Wenling Q, Mauro P, Stefano B. Antibacterial agents targeting the bacterial cell wall. Curr Med Chem 2020; 27:2902–2926 [View Article] [PubMed]
    [Google Scholar]
  39. Cochrane SA, Lohans CT. Breaking down the cell wall: strategies for antibiotic discovery targeting bacterial transpeptidases. Eur J Med Chem 2020; 194:112262 [View Article] [PubMed]
    [Google Scholar]
  40. Buijs NP, Matheson EJ, Cochrane SA, Martin NI. Targeting membrane-bound bacterial cell wall precursors: a tried and true antibiotic strategy in nature and the clinic. Chem Commun 2023; 59:7685–7703 [View Article] [PubMed]
    [Google Scholar]
  41. Kurz SG, Bonomo RA. Reappraising the use of β-lactams to treat tuberculosis. Expert Rev Anti Infect Ther 2012; 10:999–1006 [View Article] [PubMed]
    [Google Scholar]
  42. Ahmad N, Islam Z, Dhar S, Kumar P, Zaidi R. Structure and mechanism basis of β-lactam activity against Mycobacterium tuberculosis: a review of literature. Indian J Tuberc 2025; 72:424–437 [View Article] [PubMed]
    [Google Scholar]
  43. Denome SA, Elf PK, Henderson TA, Nelson DE, Young KD. Escherichia coli mutants lacking all possible combinations of eight penicillin binding proteins: viability, characteristics, and implications for peptidoglycan synthesis. J Bacteriol 1999; 181:3981–3993 [View Article] [PubMed]
    [Google Scholar]
  44. Vega D, Ayala JA. The DD-carboxypeptidase activity encoded by pbp4B is not essential for the cell growth of Escherichia coli. Arch Microbiol 2006; 185:23–27 [View Article] [PubMed]
    [Google Scholar]
  45. Wright GD, Molinas C, Arthur M, Courvalin P, Walsh CT. Characterization of vanY, a DD-carboxypeptidase from vancomycin-resistant Enterococcus faecium BM4147. Antimicrob Agents Chemother 1992; 36:1514–1518 [View Article] [PubMed]
    [Google Scholar]
  46. Todd JA, Bone EJ, Ellar DJ. The sporulation-specific penicillin-binding protein 5a from Bacillus subtilis is a DD-carboxypeptidase in vitro. Biochem J 1985; 230:825–828 [View Article] [PubMed]
    [Google Scholar]
  47. Pandey SD, Pal S, Kumar N G, Bansal A, Mallick S et al. Two dd-carboxypeptidases from Mycobacterium smegmatis affect cell surface properties through regulation of peptidoglycan cross-linking and glycopeptidolipids. J Bacteriol 2018; 200:e00760-17 [View Article]
    [Google Scholar]
  48. Pandey SD, Jain D, Kumar N, Adhikary A, Kumar N G et al. MSMEG_2432 of Mycobacterium smegmatis mc2155 is a dual function enzyme that exhibits DD-carboxypeptidase and β-lactamase activities. Microbiology 2020; 166:546–553 [View Article]
    [Google Scholar]
  49. Möll A, Dörr T, Alvarez L, Davis BM, Cava F et al. A d, d-carboxypeptidase is required for vibrio cholerae halotolerance. Environ Microbiol 2015; 17:527–540 [View Article]
    [Google Scholar]
  50. Sarkar SK, Chowdhury C, Ghosh AS. Deletion of penicillin-binding protein 5 (PBP5) sensitises Escherichia coli cells to beta-lactam agents. Int J Antimicrob Agents 2010; 35:244–249 [View Article]
    [Google Scholar]
  51. Sarkar SK, Dutta M, Chowdhury C, Kumar A, Ghosh AS. PBP5, PBP6 and DacD play different roles in intrinsic β-lactam resistance of Escherichia coli. Microbiology 2011; 157:2702–2707 [View Article] [PubMed]
    [Google Scholar]
  52. Ropy A, Cabot G, Sánchez-Diener I, Aguilera C, Moya B et al. Role of Pseudomonas aeruginosa low-molecular-mass penicillin-binding proteins in AmpC expression, β-lactam resistance, and peptidoglycan structure. Antimicrob Agents Chemother 2015; 59:3925–3934 [View Article] [PubMed]
    [Google Scholar]
/content/journal/acmi/10.1099/acmi.0.001074.v4
Loading
/content/journal/acmi/10.1099/acmi.0.001074.v4
Loading

Data & Media loading...

Supplements

Supplementary material 1

PDF
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An error occurred
Approval was partially successful, following selected items could not be processed due to error